COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy
Condition: SARS-CoV-2 Intervention: Drug: Methylene Blue and Photodynamic Therapy Sponsors: I.M. Sechenov First Moscow State Medical University; Prokhorov General Physics Institute of the Russian Academy of Sciences (GPI RAS) Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2021 Category: Research Source Type: clinical trials